Effect of Fentanyl and Midazolam with Bupivacaine in controlling nausea and vomiting in patients undergoing below waist surgeries.

A comparative study between intrathecally administered Fentanyl & Midazolam with Bupivacaine for prevention of nausea & vomiting undergoing infraumbilical surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062875

Enrollment

Registered

2024-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj. Fentanyl and Inj. Midazolam: 0.25mL Fentanyl (12.5microgm) Intrathecally, once before surgery 0.25mL Midazolam (1.25mg) Intrathecally, once before surgery Patients will be observe

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2. Patients posted for infraumbilical surgeries.

Exclusion criteria

Exclusion criteria: Patients with hypertension, CAD, rental and hepatic disease. Patients with skin disease at the site of injection. Contraindication to regional anaesthesia

Design outcomes

Primary

Measure	Time frame
To compare which amongst Fentanyl & Midazolam is better for prevention of nausea & vomiting undergoing infraumbilical surgeries.Timepoint: 48 hours post op	—

Secondary

Measure	Time frame
To compare the vital parameters between the two groups & to study any side effects or complications & treat them with utmost care Timepoint: 48 hours post op	—

Countries

India

Contacts

Public ContactNidhi Punia

Principal Investigator (PI) ( 89499 21637)

chetanshukla_pallav@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026